Australia markets closed

Next Science Limited (NXS.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.20000.0000 (0.00%)
At close: 03:56PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
22,179
22,179
11,713
8,948
3,441
-
Cost of revenue
5,945
5,945
2,563
2,007
524.134
-
Gross profit
16,235
16,235
9,150
6,940
2,917
-
Operating expenses
Research development
6,486
6,486
6,150
5,047
5,954
-
Selling general and administrative
25,776
25,776
15,695
11,501
8,792
-
Total operating expenses
33,374
33,374
22,742
17,338
15,448
-
Operating income or loss
-17,140
-17,140
-13,592
-10,398
-12,531
-
Interest expense
2,999
735.915
-
-
-
2,101
Total other income/expenses net
72.657
72.657
27.89
257.864
533.227
-
Income before tax
-16,271
-16,271
-12,683
-9,350
-11,912
-
Income tax expense
0
0
0
0
0
-
Income from continuing operations
-16,271
-16,271
-12,683
-9,350
-11,912
-
Net income
-16,271
-16,271
-12,683
-9,350
-11,912
-
Net income available to common shareholders
-16,271
-16,271
-12,683
-9,350
-11,912
-
Basic EPS
-0.07
-0.07
-0.06
-0.05
-0.06
-
Diluted EPS
-0.07
-0.07
-0.06
-0.05
-0.06
-
Basic average shares
214,826
234,095
210,468
196,883
187,185
-
Diluted average shares
214,826
234,095
210,468
196,883
187,185
-